ALBERT

All Library Books, journals and Electronic Records Telegrafenberg

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    Publication Date: 2010-04-30
    Description: Amyotrophic lateral sclerosis (ALS) has its onset in middle age and is a progressive disorder characterized by degeneration of motor neurons of the primary motor cortex, brainstem and spinal cord. Most cases of ALS are sporadic, but about 10% are familial. Genes known to cause classic familial ALS (FALS) are superoxide dismutase 1 (SOD1), ANG encoding angiogenin, TARDP encoding transactive response (TAR) DNA-binding protein TDP-43 (ref. 4) and fused in sarcoma/translated in liposarcoma (FUS, also known as TLS). However, these genetic defects occur in only about 20-30% of cases of FALS, and most genes causing FALS are unknown. Here we show that there are mutations in the gene encoding optineurin (OPTN), earlier reported to be a causative gene of primary open-angle glaucoma (POAG), in patients with ALS. We found three types of mutation of OPTN: a homozygous deletion of exon 5, a homozygous Q398X nonsense mutation and a heterozygous E478G missense mutation within its ubiquitin-binding domain. Analysis of cell transfection showed that the nonsense and missense mutations of OPTN abolished the inhibition of activation of nuclear factor kappa B (NF-kappaB), and the E478G mutation revealed a cytoplasmic distribution different from that of the wild type or a POAG mutation. A case with the E478G mutation showed OPTN-immunoreactive cytoplasmic inclusions. Furthermore, TDP-43- or SOD1-positive inclusions of sporadic and SOD1 cases of ALS were also noticeably immunolabelled by anti-OPTN antibodies. Our findings strongly suggest that OPTN is involved in the pathogenesis of ALS. They also indicate that NF-kappaB inhibitors could be used to treat ALS and that transgenic mice bearing various mutations of OPTN will be relevant in developing new drugs for this disorder.〈br /〉〈span class="detail_caption"〉Notes: 〈/span〉Maruyama, Hirofumi -- Morino, Hiroyuki -- Ito, Hidefumi -- Izumi, Yuishin -- Kato, Hidemasa -- Watanabe, Yasuhito -- Kinoshita, Yoshimi -- Kamada, Masaki -- Nodera, Hiroyuki -- Suzuki, Hidenori -- Komure, Osamu -- Matsuura, Shinya -- Kobatake, Keitaro -- Morimoto, Nobutoshi -- Abe, Koji -- Suzuki, Naoki -- Aoki, Masashi -- Kawata, Akihiro -- Hirai, Takeshi -- Kato, Takeo -- Ogasawara, Kazumasa -- Hirano, Asao -- Takumi, Toru -- Kusaka, Hirofumi -- Hagiwara, Koichi -- Kaji, Ryuji -- Kawakami, Hideshi -- England -- Nature. 2010 May 13;465(7295):223-6. doi: 10.1038/nature08971. Epub 2010 Apr 28.〈br /〉〈span class="detail_caption"〉Author address: 〈/span〉Department of Epidemiology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima 734-8553, Japan.〈br /〉〈span class="detail_caption"〉Record origin:〈/span〉 〈a href="http://www.ncbi.nlm.nih.gov/pubmed/20428114" target="_blank"〉PubMed〈/a〉
    Keywords: Adolescent ; Adult ; Aged ; Aged, 80 and over ; Amino Acid Sequence ; Amyotrophic Lateral Sclerosis/*genetics/metabolism/pathology/physiopathology ; Asian Continental Ancestry Group ; Base Sequence ; Child ; Codon, Nonsense/genetics ; Consanguinity ; Cytoplasm/metabolism/pathology ; DNA-Binding Proteins/metabolism ; Exons/genetics ; Female ; Humans ; Japan ; Male ; Middle Aged ; Mutant Proteins/analysis/chemistry/genetics/metabolism ; Mutation/*genetics ; Mutation, Missense/genetics ; NF-kappa B/agonists/antagonists & inhibitors/metabolism ; Pedigree ; Polymorphism, Single Nucleotide/genetics ; Protein Transport ; Sequence Deletion/genetics ; Superoxide Dismutase/metabolism ; Transcription Factor TFIIIA/analysis/chemistry/*genetics/metabolism ; Young Adult
    Print ISSN: 0028-0836
    Electronic ISSN: 1476-4687
    Topics: Biology , Chemistry and Pharmacology , Medicine , Natural Sciences in General , Physics
    Location Call Number Expected Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...